JW Therapeutics' Series A Round

JW Therapeutics raised a round of funding on March 08, 2018.

JW Therapeutics (药明巨诺) is an independent immuno-cell therapy company focused on the cancer market. The company is committed to the development, transformation, and promotion of first in class …

Articles about JW Therapeutics' Series A Round: